Discover 1,431 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,431
Neurocognitive Disorders After Major Surgery in Elderly
for
Anesthesia, Neurocognitive Disorders
Location: Montreal
Sponsor: Ciusss de L'Est de l'Île de Montréal
Sex: All
Age: 70+
Code: NCT04825847
Recruiting
Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic in Cancer Patients With Pain
for
Pain, Intractable
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18 - 70+
Code: NCT02687347
Phase 3, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Saint John, South Portland ME, West Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase 3, Recruiting
Abatacept for the Treatment of Giant Cell Arteritis
for
Giant Cell Arteritis
Location: New York NY, Montreal, Philadelphia PA, Toronto,
Sponsor: University of Pennsylvania
Sex: All
Age: 50+
Code: NCT04474847
Phase 3, Recruiting
Web-based Nursing Intervention to Promote Physical Activity Among Older Adults With Coronary Heart Disease
for
Older Adults, Web-based Intervention, Nursing,
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 65+
Code: NCT06197347
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ATLAS (AltaValve) Pivotal Trial
for
Mitral Regurgitation, Mitral Insufficiency,
Location: Boston MA, Quebec, The Bronx NY, New York NY,
Sponsor: 4C Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT06465745
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)